Centre Hospitalier Universitaire Rouen — Sponsor Intelligence | 38 EU Trials

Filter these 38 trials by condition, phase, country and more.

Open in Search →

38 Registered trials

21 Recruiting

6 Completed trials

1 Countries active

62 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 17 Phase II/III: 2 Phase II: 11 Phase I/II: 1 Phase III/IV: 2 Phase IV: 5

Oversight events:

2 temporary halts 1 unexpected event across 2 trials

View oversight register →

100%

6 of 6 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Colon cancer 1 Renal transplant 1 Neoadjuvant therapy 1 Colorectal cancer metastatic 1 Colorectal cancer 1

Top IMPs

ANHYDROUS CYCLOPHOSPHAMIDE 3 CAPECITABINE 3 BELATACEPT 2 D,L-LYSINE ACETYLSALICYLATE 2 FLUOROURACIL 2 LEVOLEUCOVORIN 2 OXALIPLATIN 2 REGORAFENIB 2 RITUXIMAB 2 ACETYLSALICYLIC ACID 1 ASCORBIC ACID, SODIUM ASCORBATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM SULFATE ANHYDROUS, MACROGOL 3350 1 ATEZOLIZUMAB 1

All trials

38 total

EVALUATION OF UCPVAX VACCINE +/- PEMBROLIZUMAB COMBINED WITH STANDARD TREATMENT AS ADJUVANT THERAPY IN PATIENTS WITH UNMETHYLATED GLIOBLASTO… Pending

2024-514399-42-00 Phase II 1 country UCP4
Randomized double blind controlled trial comparing the safety and efficacy of apremilast versus placebo in severe forms of recurrent aphthou… Pending

2024-514659-13-00 Phase III 1 country
Efficacy of domperidone (a prokinetic agent) on time in range in digestively asymptomatic type I diabetic patients with delayed gastric empt… Pending

2024-514838-20-00 Phase III 1 country DOMPERIDONE
Effectiveness of a preventive strategy for cytomegalovirus infection guided differently from a universal prophylactic strategy in kidney tra… Pending

2024-515925-27-00 Phase III 1 country VALGANCICLOVIR
VASCULAR AND RENAL IMPACT OF ENDOTHELIN-1 RECEPTOR BLOCKADE IN PATIENTS WITH UNCONTROLLED ARTERIAL HYPERTENSION - ENDOTHELIN-2 Pending

2024-515928-36-00 Phase II 1 country BOSENTAN
French prospective randomised double blind study on aspirin versus placebo in resected colon cancer with PI3K mutation stage III or II high … Pending

2024-516007-16-00 Phase III 1 country ACETYLSALICYLIC ACID
NEOSTART Study - NEOADJUVANT PEMBROLIZUMAB IN PATIENTS WITH HIGH RISK, STAGE IIB/IIC CUTANEOUS MELANOMA: A SINGLE ARM PROOF OF CONCEPT PHASE… Pending

2024-519573-19-00 Phase II 1 country PEMBROLIZUMAB
Evaluation of the efficacy and safety of bimekizumab (BZK) or adalimumab (ADA) in the treatment of anterior chest wall pain associated with … Pending

2025-520632-42-00 Phase III 1 country BIMEKIZUMAB
GLIFLOFASTER : EARLY GLIFLOZIN TREATMENT IN ELDERLY PATIENT HOSPITALIZED FOR DECOMPENSATED CHRONIC HEART FAILURE ADMITTED IN THE EMERGENCY … Pending

2025-521101-40-00 Phase IV 1 country
Pharmacokinetic study of the use of Nefopam 30 mg tablet in patients suffering from acute pain in rheumatology - NEFOPAIN kinetics Pending

2025-521926-13-00 Phase IV 1 country NEFOPAM HYDROCHLORIDE
Evaluation of the efficacy of iloprost in the management of vaso-occlusive crises in adult patients with sickle cell: a multicentre, randomi… Pending

2025-522005-38-00 Phase III 1 country GLUCOSE MONOHYDRATE; ILOPROST
Screening for subclinical antibody mediated rejection and efficacy of belatacept in the context of de novo donor specific antibody after kid… Recruiting

2024-516527-13-00 Phase III/IV 1 country BELATACEPT; TACROLIMUS
Postoperative anti-infective strategy following pancreaticoduodenectomy in patients with preoperative biliary stent FRENCH24 ANIS Recruiting

2024-515181-14-00 Phase III 1 country PIPERACILLIN SODIUM, TAZOBACTAM SODIUM, PIPERACILLIN, TAZOBACTAM, PIPERACILLIN M…
Safety of rotigotine in patients with autosomal dominant polycystic kidney disease - ETERNAL-PKD Recruiting

2024-515734-32-00 Phase II 1 country ROTIGOTINE
PULSE : Activity and tolerability of maintenance avelumab immunotherapy after first line polychemotherapy including a platinum salt in patie… Recruiting

2024-514997-27-00 Phase II 1 country
Risk-adapted adjuvant chemotherapy guided by the tumour stage for operated pancreatic adenocarcinoma following neoadjuvant chemotherapy with… Recruiting

2024-519048-33-00 Phase II/III 1 country FLUOROURACIL; GEMCITABINE; IRINOTECAN; LEVOLEUCOVORIN; OXALIPLATIN; PACLITAXEL
TACTIC : MP0317, A TUMOR TARGETING FAP DEPENDENT CD40 AGONIST DARPIN, IN COMBINATION WITH CHEMOIMMUNOTHERAPY IN FIRST LINE TREATMENT FOR PAT… Recruiting

2024-520029-35-01 Phase II 1 country MP0317
Interest of early erectile rehabilitation with Sildenafil after proctectomy for rectal cancer : Randomized controlled trial (RECTIL) Recruiting

2024-515431-30-00 Phase III 1 country SILDENAFIL
Comparison of the effects of Belatacept and Anticalcineurins on endothelial function in kidney transplant patients - BELAFENDO Recruiting

2024-515577-10-00 Phase IV 1 country BELATACEPT; GLYCERYL TRINITRATE
ODORAT : Optimal dose of anti-lymphocyte globulin in kidney transplant recipients with low immunological risk Recruiting

2024-514792-17-00 Phase II 1 country
Mechanisms of action on rectal motility of intrarectal botulinum toxin injections in patients with fecal incontinence - MECA-TOX Recruiting

2024-515256-21-00 Phase III 1 country ASCORBIC ACID, SODIUM ASCORBATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM SUL…
REPROGRAM-02 : Induction Regorafenib in combination with metronomic cyclophosphamide, capecitabine, and low-dose aspirin followed by chemoth… Recruiting

2024-516709-22-00 Phase II/III 1 country ANHYDROUS CYCLOPHOSPHAMIDE; CAPECITABINE; D,L-LYSINE ACETYLSALICYLATE; REGORAFEN…
Comparison of a personalized maintenance therapy based on the evolution of anti-desmoglein antibodies as biomarkers of pemphigus subclinical… Recruiting

2024-514886-21-00 Phase IV 1 country RITUXIMAB
FLUOCOL-1 : Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery to Prevent Anastomotic Leakage Recruiting

2024-515118-42-00 Phase III/IV 1 country INDOCYANINE GREEN

Showing 1–24 of 38 trials

← All sponsors A–Z